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Intrinsic Excitability Changes Induced by Acute Treatment of
Hippocampal CA1 Pyramidal Neurons With Exogenous Amyloid b
Peptide
Francesco Tamagnini,1,2* Sarah Scullion,2 Jon T. Brown,1,2 and Andrew D. Randall1,2
ABSTRACT: Accumulation of beta-amyloid (Ab) peptides in the human
brain is a canonical pathological hallmark of Alzheimer’s disease (AD).
Recent work in Ab-overexpressing transgenic mice indicates that
increased brain Ab levels can be associated with aberrant epileptiform
activity. In line with this, such mice can also exhibit altered intrinsic
excitability (IE) of cortical and hippocampal neurons: these observations
may relate to the increased prevalence of seizures in AD patients. In this
study, we examined what changes in IE are produced in hippocampal
CA1 pyramidal cells after 2–5 h treatment with an oligomeric preparation
of synthetic human Ab 1–42 peptide. Whole cell current clamp record-
ings were compared between Ab-(500 nM) and vehicle-(DMSO 0.05%)
treated hippocampal slices obtained from mice. The soluble Ab treatment
did not produce alterations in sub-threshold intrinsic properties, includ-
ing membrane potential, input resistance, and hyperpolarization acti-
vated “sag”. Similarly, no changes were noted in the firing profile evoked
by 500 ms square current supra-threshold stimuli. However, Ab 500 nM
treatment resulted in the hyperpolarization of the action potential (AP)
threshold. In addition, treatment with Ab at 500 nM depressed the after-
hyperpolarization that followed both a single AP or 50 Hz trains of a
number of APs between 5 and 25. These data suggest that acute exposure
to soluble Ab oligomers affects IE properties of CA1 pyramidal neurons
differently from outcomes seen in transgenic models of amyloidopathy.
However, in both chronic and acute models, the IE changes are toward
hyperexcitability, reinforcing the idea that amyloidopathy and increased
incidence in seizures might be causally related in AD patients. VC 2014
The Authors Hippocampus Published by Wiley Periodicals, Inc.
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INTRODUCTION
Beta-amyloid peptides (Ab) are widely believed to play an important
role in the pathogenesis of Alzheimer’s disease (AD) (Hardy and
Higgins, 1992; Pimplikar, 2009). This family of pep-
tides are produced by sequential enzymatic cleavage of
the transmembrane protein amyloid precursor protein
(APP) by the beta and gamma secretase complexes
(Citron, 2004). Mutant forms of human APP, which
are more readily processed to Ab, result in familial
early-onset forms of AD, as do mutations in the pre-
senilins, key components of the gamma secretase com-
plex that is involved in enzymatically liberating Ab
from APP (Chow et al., 2010). Central nervous sys-
tem (CNS) accumulation of soluble Ab occurs early
in the disease process and it grows as the pathology
becomes more advanced and Ab-rich amyloid plaques
also appear within the neuronal parenchyma (Jacobsen
et al., 2006; Naslund et al., 2000).
Numerous neurophysiological studies of transgenic
mice which overproduce Ab have been performed
over the last 15 years, in the attempt to understand
how AD-associated Ab pathology disturbs CNS func-
tion (Randall et al., 2010). These studies have fre-
quently concentrated on the analysis of synaptic
function and plasticity in hippocampus and cerebral
cortex (Fitzjohn et al., 2008; Jacobsen et al., 2006;
Tamagnini et al., 2012; Witton et al., 2010). More
recent studies, including our own, have looked
beyond synaptic function and have started to uncover
significant alterations in the intrinsic excitability (IE)
of single neurones in transgenic mice that over-
produce Ab. Such changes to IE have been reported
in both excitatory and inhibitory neurones of the hip-
pocampus (Brown et al., 2011; Hazra et al., 2013;
Kaczorowski et al., 2011; Kerrigan et al., 2013; Min-
keviciene et al., 2009; Wykes et al., 2012), the cortex
(Hazra et al., 2013; Verret et al., 2012), and cerebel-
lum (Hoxha et al., 2012). Clearly, such alterations to
neuronal IE have to be considered along with changes
to synaptic function, if we are to understand the
mechanisms through which increased levels of Ab
change the activity of neuronal networks.
Our own work on IE has largely focused on hippo-
campal CA1 pyramidal cells (CA1-PC) and to date it
has involved investigation of four different transgenic
Ab overproducing mouse lines. We have identified
changes to the bursting behavior of CA1-PC and
associated changes to the spike after-depolarization
(ADP) (Brown et al., 2011; Kerrigan et al., 2013).
We also found differences in the action potential
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waveform and demonstrated that these likely arise, at least in
part, from alterations to the levels of functional voltage-gated
Na1 channels (Brown et al., 2011).
Our work has led to us frequently asked whether the
changes in IE we see in Ab overproducing transgenic mice can
also be observed when acutely treating brain slices with an
exogenous Ab preparation. In the work presented in this study,
we address this question by measuring the IE properties of
CA1 hippocampal neurons in brain slices pre-treated with 500
nM soluble human amyloid beta 1–42 peptides (hAb 1–42).
The concentration used in this study has been frequently used
for in vitro studies of synaptic function and it has been shown
to both impair (Lambert et al., 1998; Lauren et al., 2009;
Puzzo et al., 2005; Wang et al., 2004) and to facilitate (Li
et al., 2009) hippocampal long-term potentiation (LTP).
METHODS
Experimental Animals
Male C57-BL6/J mice aged 4–5 weeks were used for all
experiments. These animals were group housed and maintained
on a standard 12:12 h light/dark cycle with access to food and
water ad libitum.
Preparation of Brain Slices
All procedures were performed in accordance with UK
Home Office legislation set out in the Animals (Scientific Pro-
cedures) Act (1986). The preparation of horizontal ventral hip-
pocampal slices was performed as previously described (Brown
et al., 2011; Brown and Randall, 2009). In brief, mice were
sacrificed by cervical dislocation and the brain was rapidly
removed and transferred to an ice cold (4C), sucrose-based
slicing solution comprising (in mM): sucrose, 189; D-glucose,
10; NaHCO3, 26; KCl, 3; MgSO4, 5; CaCl2, 0.1; NaH2PO4,
1.25, continuously bubbled with carbogen (95% O2, 5% CO2
gas mixture). The cerebellum, frontal and dorsal parts were
removed with single scalpel cuts. The sample was then
mounted on a metal plate on the dorsal side (i.e., ventral side
up) and 300 lm thickness horizontal sections were prepared
using a Leica VT1200 vibratome. After sectioning, slices were
submerged in a storage vessel, which contained our standard
artificial cerebrospinal fluid (aCSF) consisting of (in mM):
NaCl, 124; KCl, 3; NaHCO3, 26; CaCl2, 2; NaH2PO4, 1.25;
MgSO4, 1; D-glucose, 10, and equilibrated with carbogen. The
slices were gradually heated to 32–34C for 30 min, after
which they were stored at room temperature for 1 h before
being treated with either hAb 1–42 peptide or vehicle.
Preparation and Application of hAb 1–42
A preparation of hAb 1–42 peptide containing low N oligo-
meric species was prepared as described elsewhere (Jo et al.,
2011). In brief, synthetic hAb 1–42 was purchased from Tocris
and dissolved in 100% HFIP (1,1,1,3,3,3-hexafluoro-2-propa-
nol) to a concentration of 1 mg mL21. This solution was incu-
bated at room temperature (RT) for 1 h, vortexing every 5–10
min. The preparation was then sonicated for 10 min at RT.
The HFIP/peptide solution was subsequently dried down
under a gentle stream of nitrogen. Following this, the dried
peptide was re-suspended in 100% DMSO to a concentration
of 1 mM and incubated for 12 min at RT, gently rotating the
vial and vortexing every few minutes. This preparation was
then pipetted into 10 lL aliquots and stored at 280oC. On
the day of use, a single aliquot was rapidly thawed and 90 lL
of PBS 0.1M added before performing 90–120 min of rotation
and gentle agitation. Following this, the Ab preparation was
finally diluted 1:2000 into standard aCSF to a final Ab con-
centration of 500 nM and applied to slices for 2–5 h before
electrophysiological recording. Control slices were exposed for
a similar period to vehicle only (0.05% DMSO); use of this
vehicle control group is particularly important as we have
shown that this concentration of DMSO can alone change IE
of cortical and hippocampal neurons (Tamagnini et al., 2014).
Notably, Ab was not applied during the recording phase of our
experiments, thus any changes observed arise from the prior
period of pre-treatment performed before the tissue was trans-
ferred to the electrophysiological recording setup.
The most commonly reported neurophysiological actions of
oligomeric Ab preparations are on long-lasting, activity-
dependent, forms of synaptic plasticity such as LTP and long-
term depression (Randall et al., 2010). Pre-incubating cortical
slices with the Ab preparation we use here is able to reliably
modify synaptic plasticity, completely abolishing the LTD in
perirhinal cortex that can be evoked using a 5 Hz conditioning
stimulus (S.S., J.B., and A.R. unpublished observations).
Electrophysiological Methods
Effects of exogenous Ab on IE were studied using single cell
patch clamp recording from CA1-PC. The recording methods
we used are similar to those we used for our previous studies
of intrinsic properties of this cell type in both Ab-
overproducing transgenic mice and healthy aged animals
(Brown et al., 2011; Kerrigan et al., 2013; Randall et al.,
2012). In brief, slices were placed into a submersion style
recording chamber, which was continuously perfused (2 mL
min21) with carbogen-equilibrated aCSF at 336 1C. CA1
pyramidal neurones in the CA1 subfield of the hippocampus
were visually identified using infra-red (IR) differential interfer-
ence contrast optics. Pipettes were fabricated from borosilicate
glass and were fire polished such that their resistance was 2.5–
4.5 MX when filled with pipette solution. The pipette solution
consisted of (mM): K-gluconate, 135; NaCl, 5; HEPES free
acid, 10; EGTA, 0.2; Na-GTP, 0.3; Mg-ATP, 4; Biocytin 13.4,
Alexafluor 488 hydrazide 0.03–0.06, pH 7.3, 280–290 mOsm.
After forming the giga-seal and then entering the whole cell
configuration in voltage-clamp mode, the amplifier was imme-
diately switched to bridge-mode current-clamp, in which all
experiments were performed. The pairing of the pipette
Ab ALTERS INTRINSIC NEURONAL PROPERTIES 787
Hippocampus
solution and the aCSF produces a liquid junction potential
error of 15 mV; this was corrected for arithmetically in all data
sets. All recordings were made using a MultiClamp 700B
amplifier (Molecular Devices, Union City, CA). Recordings
were low pass filtered (5–10 kHz) and then digitised (20–
100 kHz) with a Digidata 1440 and stored on a personal com-
puter using pClamp10 electrophysiology software.
In Vitro Electrophysiology Protocols and Data
Analysis
Analysis of current-clamp recordings, including action
potential waveform analysis was performed with custom-
written routines within the Matlab environment. Resting
potential was measured as soon as possible after starting record-
ing. Following determination of resting potential, for all other
measurements the pre-stimulus membrane potential was set to
280 mV (this value includes the junction potential correc-
tion—the amplifier reads 265 mV during the experiment)
using the appropriate amount of current injection (x5, Fig. 1).
Membrane resistance was analyzed in multiple ways. The first
measure (Rin-exp) assessed resting input resistance independently
of the “sag”-producing Ih activation that occurs during hyper-
polarizing current steps. This was calculated using Ohm’s law
from the amplitude of an infinite time extrapolation of a single
exponential curve fitted to the membrane charging response
generated by a 2100 pA current injection (Fig. 1, arrow B).
The exponential fit was made between points at 10 and 95%
of peak amplitude. This fit was also used to determine mem-
brane time constant and to determine one measure of the
extent of sag (see below). Secondly, the reduced measure of
input resistance, which includes the contribution from addi-
tional Ih activation (Rin-ss) was calculated using Ohm’s law by
determining the steady-state (post-sag) voltage deflection pro-
duced by a 500 ms, 2100 pA stimulus (Fig. 1, arrow C).
Finally, the input resistance at 280 mV (Rin-slope) was also
measured (as the reciprocal of slope conductance) using linear
regression of the steady state voltage responses elicited by a
series of eight low amplitude (250 to 130 pA), 500 ms dura-
tion current steps (Fig. 3A).
Hyperpolarization-activated sag was measured in two ways.
The first measurement (sagsub) simply expressed the difference
between the peak (Fig. 1, arrow A) and steady state hyperpola-
rizations produced by a 500-ms, 2100-pA current injection as
a percentage of the peak hyperpolarization, i.e., 100 * (A–C)/A
(in Fig. 1). The second measure of sag (sagfit) measured the
decay in response relative to the amplitude of the infinite time
extrapolation used to determine Rin-exp i.e., 100* (B–C)/B (Fig.
1). In addition to sag, the amplitude of the sag-related rebound
depolarization was also measured relative to the pre-stimulus
membrane potential (Fig. 1, arrow D). All the passive proper-
ties were statistically compared between groups using unpaired
Student’s t-test.
Membrane resonance was measured with standard “ZAP”
protocols, in which a low amplitude sinusoidal current injec-
tion of linearly increasing frequency was applied to the cell
causing voltage deflections of around 5–10 mV, as previously
described (Hu et al., 2002). The impedance profile was calcu-
lated as the ratio between the fast Fourier transform of the
voltage response (V(fft)) and current injection (I(fft)):
Z5V(fft)/I(fft); the impedance versus frequency profile was
subsequently smoothed with a moving average function with a
span of 35 data-points. The parameters analyzed to test the
effect of treatment on the sub-threshold resonance properties
of CA1 pyramidal neurons were the peak frequency, the peak
impedance and the quality factor of the resonator Q; unpaired
Student’s t-test was used to test the effect of treatment on
resonance.
Depolarizing current injections of 500 ms duration and
amplitude varying stepwise from 50 to 300 pA were used to
elicit action potential (AP) firing. From these, the relationship
between the stimulus amplitude and the number and pattern of
APs elicited was examined. The firing properties illustrated in
Figures 4 and 5 were examined between groups using two-way
analysis of variance (ANOVA). To assess individual AP wave-
forms, the first spike fired by a 300 pA current injection was
analyzed, as this size of stimulus elicited an AP in all cells. AP
threshold was determined from phase plots as the voltage, at
which dV/dt surpassed 20 V s21 (Naundorf et al., 2006). Spike
width was measured at 215 mV, which is approximately half-
way between threshold ( 260 mV) and action potential peak
( 130 mV). The AP properties were statistically compared
between groups using unpaired Student’s t-test.
FIGURE 1. Schematic representation of the determination of
passive membrane properties from a hyperpolarizing current step.
To assess IE properties of CA1 pyramidal neurons, whole cell cur-
rent clamp recordings were performed. For each recording, a
“holding” current (x pA) was injected to keep the unstimulated
Vm at the fixed value of 280 mV. A 500-ms long, 2100-pA ampli-
tude current was injected to assess the passive properties of the
neuronal membrane. The input resistance was measured at the
steady state of the Vm deflection (arrow C) or at the infinite time
extrapolation (arrow B) of the single exponential fit to points
between 10–95% of the negative peak (arrow A). The exponential
fit was also used to calculate the membrane time constant s. Sag
was calculated both from the decline from the observed negative
peak [(A–C)/A)] and from the Vm extrapolated at the infinite time
of the exponential fit [(B–C)/A)]. Sag is mirrored by a positive
rebound of the potential following the interruption of the hyper-
polarizing current step (D).
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Voltage responses were also measured to single, brief (2 ms),
strong (2 nA) current injections. This stimulus usually elicits a
single AP, which is followed in hippocampal pyramidal cells by
a fast ADP, followed in turn by a brief small after-
hyperpolarization (AHP). Unpaired Student’s t-test was used to
compare the ADP and AHP elicited by a single spike.
Finally, to further test the effect of treatment on post-burst
firing AHP, trains of 5–10–15–20–25 2 ms/2 nA square cur-
rent pulses were delivered at a frequency of 50 Hz; the
medium AHP was measured as the most hyperpolarized point
in the 500 ms following the descending phase of the last AP
reaching 0 mV. Two way ANOVA was used to statistically
assess the effect of treatment on the medium AHP amplitude
elicited by 50 Hz spike trains.
RESULTS
Our studies of the effects of exogenous Ab on IE of CA1-
PC were focused on slices treated with 500 nM peptide (initial
monomer concentration). Although high compared to global
average levels in AD brain measured in Ab-overexpressing
transgenic mouse models of amyloidopathy (0.5 nM)
(Waters, 2010), this concentration is probably the most com-
monly used in neurophysiological studies of brain slices,
including a large body of data on Ab effects on synaptic plas-
ticity (Lambert et al., 1998; Lauren et al., 2009; Ma et al.,
2011; Parameshwaran et al., 2007; Puzzo et al., 2005; Randall
et al., 2010; Wang et al., 2004). The concentration of Ab 1–
42 soluble oligomers tends to decrease with age; this is particu-
larly true in AD patients, where the ratio between the insolu-
ble:soluble fraction of Ab is significantly higher, as showed in
>60 yrs post-mortem human AD brains versus age-matched
controls, presumably because of the aggregation of soluble Ab
into insoluble fibrils and plaques (van Helmond et al., 2010).
The physiological relevance of using this concentration (500
nM) relies on the fact that the average levels of Ab 1–42 solu-
ble oligomers in the AD brain can disguise the peri-plaque
concentration gradient of this species, which might differen-
tially affect the neuronal function depending on the distance
from the plaque itself.
Pre-exposure for 2–5 h duration to 500 nM of Ab had no
effect on resting membrane potential (Fig. 2A). Figure 2B
presents average voltage responses to 2100 pA and 150 pA
current stimuli applied at a fixed prestimulus potential of 280
mV both for vehicle and Ab treated cells. It is readily apparent
that the responses are similar. This is confirmed by the cell by
cell analysis of responses to 2100 pA current stimuli, presented
in Figures 2C–H. Thus, membrane resistance measured as both
Rin-ss and Rin-exp (see methods) was unaltered (Figs. 2C,D;
respectively). The sag observed in response to a 2100 pA hyper-
polarizing current step was not altered. This was the case when
the sag was measured as peak hyperpolarization relative to the
steady state (sagsub, Fig. 2E) or using an exponential fit to the
membrane charging (sagfit, Fig. 2F); likewise the sag-related
rebound depolarization observed on cessation of the current
injection was also not altered following incubation in Ab (Fig.
2G). Membrane time constant was also not changed by Ab
application (Fig. 2H). The lack of effect of Ab on membrane
resistance was also confirmed when an incremental series of
small current pulses was applied to the cells and voltage versus
current plots were constructed (Figs. 3A–C). For mean values
see Table 1.
The activation/deactivation properties of various ion channels
with significant voltage-dependent gating near to resting poten-
tial can create membrane resonance in neurones. In CA1-PC
this is typically seen around 5 Hz and results from the activity
of HCN channels and low threshold K1 channels such a Kv7
family members. We analyzed resonance properties in 21 Vehi-
cle and 21 hAb 1–42 oligomers treated neurones. As shown in
Figure 3D there was no difference between the groups. This
was the case for the peak resonant frequency, the peak imped-
ance and the quality factor Q of the resonator (see Table 2).
The data in Figures (2 and 3) indicate we were unable to
find any significant difference in sub-threshold membrane
properties between control cells and those exposed to 500 nM
Ab for between 2 and 5 h. This lack of alteration to sub-
threshold intrinsic properties is in good agreement with our
work in transgenic mice where the major differences are seen
in supra-threshold parameters. Thus, to study AP firing pat-
terns of CA1-PC, we depolarized the cells with 500 ms current
injections ranging in amplitude from 50 to 300 pA (Fig. 4A
shows the response of an example cell from the two treatment
groups at three different current intensities). The plot in Figure
4B presents the mean number of spikes fired for each stimulus
amplitude (including sweeps where no spikes occurred). This
illustrates that almost identical numbers of spikes were pro-
duced in the 25 hAb 1–42 oligomers- and 24 vehicle-treated
cells studied. A similar outcome is apparent from Figure 4C,
which also plots the number of spikes fired for each stimulus,
but only includes data from sweeps in which at least one action
potential was produced. For the 300 pA current injection the
mean peak amplitude of the first 10 APs fired is shown in Fig-
ure 4D: no difference was observed between the two treat-
ments. Finally, no difference was observed in the fraction of
cells firing one or more APs in response to a depolarizing cur-
rent step of increasing intensity (Fig. 4E).
In aged PSAPP transgenic mice stimulated with relatively
weak supra threshold current injections, the pattern of AP fir-
ing in CA1-PC during 500 ms depolarizations was significantly
altered compared to wild-type littermates (Brown et al., 2011).
In particular, the transgenic mice exhibited a more pronounced
burstiness soon after the onset of the current injection. We
have recently seen a somewhat similar phenotype in the
PDAPP transgenic line (Kerrigan et al., 2013). Such an effect
is best illustrated in plots of instantaneous spiking frequency
versus spike interval number. Such plots, comparing hAb 1–42
oligomers- and vehicle-treated slices for four different levels of
current injection, are shown in Figures 5A–D. It is clear that a
short exposure to a high (500 nM) concentration of hAb 1–42
oligomers, was not able to alter the AP by AP profile of
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instantaneous frequency in a way similar to that we reported in
the Ab overproducing transgenic mice (Brown et al., 2011;
Kerrigan et al., 2013).
The post-spike ADP is a major determinant of burstiness in
hippocampal pyramidal cells, and was larger in PSAPP mice
(Brown et al., 2011). In this study, commensurate with the
lack of change in AP firing dynamics, the ADP amplitude fol-
lowing a single spike was not modified in hAb 1–42 oligomer-
treated slices (vehicle 16.66 1.2 mV, versus hAb 1–42
oligomer 15.26 1.1 mV, P5 0.4). Thus, an acute 2–5 h
FIGURE 2. Pretreatment with soluble hAb 1–42 oligomers
does not alter sub-threshold intrinsic properties in CA1-PC (A) A
scatter/box plot of zero current potential recorded from vehicle
and Ab pre-treated CA1-PC. In this and all other similar plots,
the symbols to the left represent data from individual neurones,
whereas the box to the right plots the mean (central symbol) plus
the upper and lower bounds of the standard error and the median.
In this and all other figures, data from vehicle treated neurones
are presented in black and data from Ab pre-treated cells are
shown in grey. (B) A plot of the average voltage response to both
2100 (downwards) and 150 pA (upwards) current stimuli applied
to CA1-PC. The thicker central line corresponds to the mean
whereas the two adjacent thinner lines represent the bounds
encompassed by one standard error of the mean. (C–H) Scatter
plots of sub-threshold intrinsic properties derived from 2100 pA
stimuli applied at a fixed membrane potential of 280 mV.
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treatment with 500 nM hAb 1–42 oligomers was not sufficient
to produce the same changes in IE and AP firing previously
observed in Ab-overproducing transgenic mice.
In CA1-PC of PSAPP transgenic mice, other than finding
more “bursty” firing patterns, we also identified changes to the
properties of individual action potentials (Brown et al., 2011).
For example, analysis of the first AP fired by 300 pA depolariz-
ing current injections showed that, on average, APs rose more
slowly, had a lower zenith, and were also narrower in width at
215 mV. The former two changes are likely to result from the
deficit in Na1 channels we described in CA1-PC using macro-
patch recording (Brown et al., 2011). In this light, we exam-
ined if acute hAb 1–42 oligomers treatment was able to
modify the AP waveform in CA1-PC. To do this, we examined
the properties of the first AP fired in response to a 300 pA
stimulus (as we had performed in our work in transgenic
mice). The amplitude of the AP was not modified (Fig. 6A,
and see also the first data point in Fig. 4D), nor was the AP
FIGURE 3. Soluble hAb 1–42 oligomer pre-treatment does not
alter membrane resistance and impedance in CA1-PC (A) Voltage
responses (bottom) from an example CA1-PC elicited by a series of
500 ms current stimuli varying in amplitude between 250 and
130 pA (top). (B) Pooled data from a number of recordings simi-
lar to and including the one shown in (A). The graph plots steady-
state voltage deflection versus current stimulus: the slope of the
interpolated straight line for each group represents the input resist-
ance, in accordance with the Ohm’s law V5RI. (C) A scatter plot
of input resistance derived from recordings like that in (A). Each
symbol represents the slope-derived input resistance derived from a
straight line fit through all the data points obtained from a single
recording. (D) The top panel shows a plot of mean impedance ver-
sus stimulus frequency for vehicle control (black) and hAb 1–42
500 nM-treated (grey) CA1-PC. The thicker central line represents
the mean values, and the dashed lines the bounds of one SEM.
The bottom panel shows an example trace of the Vm of CA1
pyramidal cell resonating in response of the injection of a sinusoi-
dal current injection of increasing frequency. The impedance Z(X)
is measured as Z5V(fft)/I(fft). The quality factor of the resonator,
Q, is calculated as the ratio between the Z at peak frequency and Z
at the frequency of 1 Hz (Q5Zpeak/Z1Hz).
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maximum rate of rise (RoR) (Fig. 6B). Furthermore, the spike
width was not different when measured at 215 mV (Fig. 6C)
or at spike threshold (vehicle, 1.591 0.09 ms versus hAb 1–42
oligomer-treated 1.666 0.12 ms, not shown). The spike
threshold, however, was altered, having moved some 3 mV
more negative in the hAb 1–42 oligomer-treated neurones
(Fig. 6D). Given that resting potentials were similar in both
groups (Fig. 2A) this means that CA1-PC in hAb 1–42
oligomer-treated slices require around 15% less depolarizing
drive to reach spike threshold (see Table 3 for averages and
SEM).
Following short bursts of action potential firing, hippocam-
pal pyramidal cells exhibit an AHP. The size of this after-
potential is reported to change during normal aging (Oh et al.,
2010), an effect that has been postulated to play a role in age-
related cognitive decline (Luebke and Amatrudo, 2012; Oh
et al., 2010). Previous reports suggest that this AHP is modi-
fied in Ab-overproducing mice, although both increases (Kac-
zorowski et al., 2011) and decreases have been reported
(Kerrigan et al., 2013).
To investigate how Ab affected AHPs following bursts of AP
firing we used repeated brief, strong current injections (2 nA, 2
ms) to induce CA1-PCs to fire trains of AP at 50 Hz. The
trains consisted of 5, 10, 15, 20, or 25 APs. In CA1-PC from
control slices such stimuli reliably evoked a mAHP; in contrast,
mAHPs were completely absent in many cells from Ab treated
slices. Furthermore, in the peptide treated cells a postburst
ADP not seen in control cells and lasting a few hundred ms
was apparent. This is illustrated in Figure 7, which presents the
group average voltage responses following 25 AP evoked at 50
Hz compiled from 9 Ab-treated and 14 control CA1-PC. An
essentially similar finding was made for 50 Hz AP trains com-
prised of 5, 10, 15, or 20 stimuli. The maximal mAHP ampli-
tude seen following each of the 50 Hz trains was measured in
each cell and compared across groups. This showed a signifi-
cant depression of the mAHP following Ab (500 nM) treat-
ment (n5 9) compared to vehicle treated slices (n5 14,
P< 0.005). Similarly the AHP observed in CA1-PC after a sin-
gle AP (elicited with a single 2 nA current injection lasting 2
ms) was also around 50% smaller in Ab treated slices (control:
1.26 0.2 mV (n5 17) versus Ab: 0.66 0.1 mV, (n5 17),
P< 0.02).
DISCUSSION
On the basis of multiple lines of evidence, soluble Ab pep-
tides are still regarded by many as key pathological species in
AD, potentially contributing to both pathogenesis and disease
progression (Hardy and Selkoe, 2002; Hardy and Higgins,
1992). Thus, in attempts to better understand the patho-
physiological mechanisms underlying AD, numerous studies
focusing on the biological actions of acutely administered exog-
enous soluble Ab peptides have been made both in vivo (An
et al., 2013; Brouillette et al., 2012; Klyubin et al., 2013) and
in vitro (Lambert et al., 1998; Lauren et al., 2009; Li et al.,
2009; Minkeviciene et al., 2009; Parameshwaran et al., 2007;
Puzzo et al., 2005; Wang et al., 2004). The other major
approach to understanding Ab biology focuses on the use of
mouse lines transgenically engineered to overproduce Ab pep-
tide species, a model of more chronic exposure to Ab species.
Some recent studies, including our own have used Ab-
overproducing mice to identify changes to the intrinsic electri-
cal properties of neurones (Brown et al., 2011; Hazra et al.,
2013; Hoxha et al., 2012; Kaczorowski et al., 2011; Kerrigan
et al., 2013; Randall et al., 2012; Wykes et al., 2012). Due to
the nature of these models, when studied experimentally brain
tissues might have been exposed to increased Ab levels, in vivo,
for up to 2 years, a time only limited by the natural lifespan
of laboratory mice. In this study, we investigated the effect on
IE of CA1-PC of acute in vitro exposure to soluble hAb 1–42
oligomers. Clearly, this is a different scenario to chronic in vivo
exposure, but one that has been frequently used by others with
interests in determining the multifaceted functional actions of
Ab peptides.
Our investigations were based on hAb pre-treatment of
acutely prepared mouse hippocampal slices for a period of 2–
5 h. This time was selected as a balance between allowing a
reasonable time for Ab effects to be produced and considera-
tion of the inevitable decline in the health of brain slices that
occurs with time in vitro. Slices were treated with either soluble
1–42 oligomers 500 nM (which included 0.05% DMSO) or
vehicle alone (i.e., DMSO 0.05%). It appears especially impor-
tant to perform the correct vehicle control in studies such as
this as we have recently demonstrated that 2–5 h treatment
with 0.05% DMSO alters IE properties of both CA1-PC and
pyramidal neurons in perirhinal cortex (Tamagnini et al.,
2014). Similarly, investigations into the consequences of acute
exogenous Ab exposure have been clouded over the years by
debate over the “right” peptide preparation to use. We used an
Ab preparation that was at least shown to be active against
TABLE 1.
Comparison of Passive Membrane Properties of CA1 Pyramidal Neu-
rons Pretreated With Vehicle (DMSO5 0.05%) Versus hAb 1–42
Oligomers 500 nM
Property
Veh.
(n5 24)
hAb 1–42
(n5 25)
PAverage SEM Average SEM
RMP (mV) 273.76 1.32 275.04 1.15 0.47
Rin-ss (MX) 78.36 5.36 80.88 7.03 0.78
Rin-exp (MX) 110.28 6.89 114.68 12.03 0.75
sagsub (%) 23.47 1.18 21.85 1.31 0.36
sagfit (%) 29.36 1.20 28.13 1.68 0.56
Rebound (mV) 2.20 0.16 2.16 0.23 0.87
tau (ms) 14.34 0.94 15.96 1.30 0.32
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synaptic plasticity both by others (Jo et al., 2011) and also
within our own group (see methods).
In previous reports by other groups, certain neurophysio-
logical effects of Ab peptides have been reported to be detect-
able within short exposure periods. For example, the
inhibition of long-term potentiation is reported to require less
than 1 h of Ab pre-treatment and maybe as little as 10 min
in vivo (Cullen et al., 1997, 1996); indeed this group, who
are perhaps the most prolific investigators of Ab and hippo-
campal synaptic plasticity, use a standard treatment time in
vivo of 15 mins. Also with regard to the time-course of action
of exogenous Ab it has also been reported that a single in
vivo injection can inhibit induction of synaptic plasticity 7
days later (Klyubin et al., 2013). Our experiments used what
FIGURE 4. Pre-treatment with soluble hAb 1–42 oligomers
does not alter the firing properties of CA1-PC (A) Example traces
from either vehicle or Ab treated CA1-PC firing APs in response
of supra-threshold 500 ms current stimuli. (B) The treatment with
Ab oligomers did not have a significant effect on the overall num-
ber of APs fired by CA1-PC in response to 50–300 pA, 500 ms
current stimuli, including or excluding (C) the cells that did not
fire at least one action potential. (D) Pretreatment with Ab
oligomers did not have a significant effect on AP zenith measured
within the first 10 spikes. (E) The treatment with Ab oligomers
did not alter the fraction of firing cells observed at each applied
current intensity.
Ab ALTERS INTRINSIC NEURONAL PROPERTIES 793
Hippocampus
has been perhaps the most commonly used concentration of
exogenous Ab for in vitro studies of brain slices, namely 500
nM. We found that pre-treatment for 2–5 h with this concen-
tration of peptide (the same treatment that will inhibit synap-
tic plasticity) left many basic intrinsic properties of CA1-PC
unaltered, including resting potential, input resistance and
any other sub-threshold property. Ab treatment did, however,
produce both a negative shift in action potential threshold
and a depression of the substantial mAHP that usually arises
after 50 Hz trains of AP firing. Indeed, in many cells the
mAHP was not only lost but appeared to be replaced with a
slow ADP.
A more hyperpolarized AP threshold and a depressed AHP
(and appearance of an ADP) after spike firing are both actions
that would typically be regarded as a net increase in excitability.
For the former this is because following Ab exposure a smaller
change from resting potential would be required to induce AP
production. For the latter, the changes to spike afterpotential
would enable spiking to be re-established more readily after a
prior burst. Certainly, hyperexcitability in cortical and hippo-
campal circuits of Ab over-expressing mice is an increasingly
reported phenomenon, and has been discussed in the frame-
work of the increased risk of seizures found in AD suffers,
most notably in early onset cases: the changes to intrinsic prop-
erties described here may contribute to this phenomenon
TABLE 2.
Comparison of Resonance Properties of CA1 Pyramidal Neurons
Pretreated With Vehicle (DMSO5 0.05%) Versus hAb 1–42 Oligomers
500 nM
Veh
(n5 21)
hAb 1–42
(n5 21)
PMean SEM Mean SEM
Peak frequency (Hz) 5.17 0.43 4.58 0.51 0.38
Q 1.21 0.03 1.15 0.02 0.18
Peak Z (MX) 105.83 9.31 115.99 8.79 0.43
FIGURE 5. Pretreatment with soluble hAb 1–42 oligomers does not alter the firing dynam-
ics of CA1-PC The instantaneous frequency of AP firing in CA1-PC is higher during the early
part of a depolarizing stimulus and subsequently accommodates to a steady slow rate of firing.
Treatment with Ab oligomers did not alter the “burstiness” of CA1-PCs (A–D).
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(Brown et al., 2011; Kerrigan et al., 2013; Minkeviciene et al.,
2009; Palop et al., 2007).
An interesting insight from these results is the comparison
with transgenic models of amyloidopathy, where the exposure
of CA1 pyramidal neurons to increased Ab is chronic, typically
lasting months or longer. Recent studies showed that PSAPP
(Brown et al., 2011), PDAPP (Kerrigan et al., 2013), and
CRND8 (Wykes et al., 2012) mice do not show any difference
from wild-types in the AP threshold of CA1-PC, but they all
consistently show a decreased spike width—something we have
also found in Tg2576 and TAS-TPM Ab overproducing mice
(unpublished observations). A possible explanation of this dis-
crepancy between the chronic and the acute models of amy-
loidopathy might be the increased potassium channel
expression, described as an early consequence in one transgenic
model (Wykes et al., 2012). Such a change could act as a com-
pensatory response to a decreased AP threshold arising from
more acute exposure to Ab. Indeed, the presence of time-
dependent compensatory changes arising from brain plasticity
are a constant challenge for those working with chronic disease
models.
The global Ab concentration in the brain of Ab overproduc-
ing transgenic mice is likely to be much lower than the 500
nM Ab 1–42 concentration used in this study for acute slice
pre-treatment. Indeed, in terms of clinical AD, the commonly
used Ab concentration we used to treat slices with is high.
Mean global levels of soluble Ab 1–42 in the brains or CSF of
AD sufferers are typically in the low pM range. It remains pos-
sible, however, that higher levels are present within certain
FIGURE 6. Soluble hAb 1–42 oligomer pre-treatment results
in the hyperpolarization of action potential threshold. (Top left)
The average waveforms6 SEM of the first action potential fired in
response of a 500 ms duration 300 pA amplitude current stimulus
for vehicle (black) or Ab oligomers treated (grey) cells; note the
more hyperpolarized AP threshold in the latter group. (Top right)
A phase–plane plot of mean AP RoR vs. Vm for the two treatment
groups. A-D Scatter/box plots describing the effect of Ab treat-
ment on the single AP properties: only AP threshold is signifi-
cantly altered, *5 P< 0.05.
TABLE 3.
Comparison of AP Properties in Control CA1 Pyramidal Neurons
Pre-treated With Vehicle (DMSO50.05%) Versus hAb 1–42 Oligomers
500 nM
Veh
(n5 24)
hAb 1–42
(n5 25)
PMean SEM Mean SEM
APpeak (mV) 34.46 1.50 33.95 1.05 0.78
APwidth (ms) 0.75 0.03 0.69 0.02 0.10
APthres (mV) 254.98 0.70 257.40 0.79 0.03
APmax_dvdt (Vs
21) 530.42 18.85 549 16.09 0.45
FIGURE 7. Soluble hAb 1–42 oligomer pretreatment impairs
postburst AHP. Group average post AP-train responses from 9 Ab-
treated and 14 control cells. A total of 25 AP were evoked in each
cell as shown by the arrow. The poststimulus mean voltage
responses are shown by the thick black traces and the extent of
the standard error of the mean is represented by the grey lines.
The dashed horizontal line represents the resting potential before
the AP train (i.e., 280 mV); thus afterpotentials below this are
AHPs and afterpotentials above it are ADPs. Note the presence of
a clear AHP lasting around 150 ms in the control cells whereas
Ab treated cells are characterized by an ADP.
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CNS niches, for example in the vicinity of amyloid plaques or
perhaps within synaptic clefts.
When presenting our previous research on transgenic mice
that overproduce Ab we have often been asked if we observe
similar behaviors when applying soluble Ab peptides acutely. By
performing many similar measurements to those we made previ-
ously in PSAPP (Brown et al., 2011), PDAPP (Kerrigan et al.,
2013), and other mice this study has partially addressed this
question here. It is, however, worth considering if it would even
be reasonable to expect to see similar changes in Ab overproduc-
ing transgenic mice and following acute Ab treatment. Although
both interventions involve exposure to Ab the nature of the
exposure is different in each case. Transgenic mice engineered to
overproduce Ab start life with normal, low Ab loads and gener-
ate increased levels over many months, although in different
mouse-lines the rate of development and extent of the amyloid
pathology is different (Lithner et al., 2011). However, at the
time-points they are usually studied, the circuits under investiga-
tion have often experienced an increased Ab load for many
months. Furthermore, as indicated above, the CNS is plastic
exhibiting multiple adaptive mechanisms including changes to
gene expression patterns that can remodel the physiology of
cells. Thus if they are perturbed acutely, for example by Ab, the
cells of the CNS are likely, over time, to reshape their physio-
logy in multiple ways. This could likely lead to different neuro-
physiological outcomes compared to those produced by acute
Ab exposure over a few hours. Relating to this, AD sufferers are
now thought to reflect outcomes of detrimental processes that
have been established over many years, some of which may
involve Ab: in this regard, the transgenic mouse may be a better
model of aspects of the pathophysiology of the AD brain during
the progression phase, whereas the acute Ab actions may tell us
important information about the early biological processes that
trigger subsequent adaptive and pathological changes.
It may be useful in future to investigate the cellular basis of
the changes to IE that are produced by acute Ab treatment. The
altered AP threshold is likely to be a consequence of a change to
voltage-gated Na1 channels. This is something which could pos-
sibly be investigated with voltage-clamp studies of nucleated mac-
ropatches, an approach we have used previously to identify Na1
channel changes underlying altered IE both in mouse models of
amyloidopathy (Brown et al., 2011) and associated with normal
aging (Randall et al., 2012). Given the prominent role of intra-
cellular Ca21 in CA1-PC AHPs, the altered afterpotentials seen
following Ab treatment may reflect a change to activity-
dependent intracellular Ca21 signalling, something that might
best be examined further with cellular imaging methodologies.
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